Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Tumor Marker ELISA Kit Market Research Report 2024

Global Tumor Marker ELISA Kit Market Research Report 2024

Industry: Medical Devices & Consumables

Published Date: 2024-10-27

Pages: 97 Pages

Report ld: 3359160

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Tumor Marker ELISA Kit Market Size(US$)

CAGR 2024-2030

7.4%

Market Size,2030

USD 4,395

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 2,864 million

Market Forecast in 2030(Value)

US$ 4,395 million

CAGR

7.4%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Tumor marker ELISA kit (enzyme-linked immunosorbent assay kit) is a tool used to detect the content of tumor markers in biological samples (such as blood, serum, plasma, tissue homogenate, etc.). ELISA (enzyme-linked immunosorbent assay) is a detection technology based on antigen-antibody specific reaction, and this kit applies this technology to the detection of tumor markers. It mainly uses the specific binding reaction between antigen and antibody.

The global Tumor Marker ELISA Kit market was valued at US$ 2659 million in 2023 and is anticipated to reach US$ 4395 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.

North American market for Tumor Marker ELISA Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tumor Marker ELISA Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Tumor Marker ELISA Kit include Thermo Fisher Scientific, Fujirebio, Siemens Healthineers, Roche Holding, Cusabio, Epitope Diagnostics, Getein Biotech, Creative Diagnostics, Artron Laboratories, InTec, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Tumor Marker ELISA Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Marker ELISA Kit.

The Tumor Marker ELISA Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tumor Marker ELISA Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tumor Marker ELISA Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Thermo Fisher Scientific

Fujirebio

Siemens Healthineers

Roche Holding

Cusabio

Epitope Diagnostics

Getein Biotech

Creative Diagnostics

Artron Laboratories

InTec

JOYSBIO

Orient Gene

Assure Tech

Microprofit Biotech

Hotgen Biotech

Segment by Type

Blood Testing

Urine Testing

Others

Segment by Application

Lung Cancer

Breast Cancer

Stomach Cancer

Liver Cancer

Esophageal Cancer

Others

Consumption by Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East and Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Tumor Marker ELISA Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Tumor Marker ELISA Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Tumor Marker ELISA Kit Market Overview

1.1 Product Definition

1.2 Tumor Marker ELISA Kit by Type

1.2.1 Global Tumor Marker ELISA Kit Market Value Comparison by Type (2024-2030)

1.2.2 Blood Testing

1.2.3 Urine Testing

1.2.4 Others

1.3 Tumor Marker ELISA Kit by Application

1.3.1 Global Tumor Marker ELISA Kit Market Value by Application (2024-2030)

1.3.2 Lung Cancer

1.3.3 Breast Cancer

1.3.4 Stomach Cancer

1.3.5 Liver Cancer

1.3.6 Esophageal Cancer

1.3.7 Others

1.4 Global Tumor Marker ELISA Kit Market Size Estimates and Forecasts

1.4.1 Global Tumor Marker ELISA Kit Revenue 2019-2030

1.4.2 Global Tumor Marker ELISA Kit Sales 2019-2030

1.4.3 Global Tumor Marker ELISA Kit Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Tumor Marker ELISA Kit Market Competition by Manufacturers

2.1 Global Tumor Marker ELISA Kit Sales Market Share by Manufacturers (2019-2024)

2.2 Global Tumor Marker ELISA Kit Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Tumor Marker ELISA Kit Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Tumor Marker ELISA Kit, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Tumor Marker ELISA Kit, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Tumor Marker ELISA Kit, Product Type & Application

2.7 Global Key Manufacturers of Tumor Marker ELISA Kit, Date of Enter into This Industry

2.8 Global Tumor Marker ELISA Kit Market Competitive Situation and Trends

2.8.1 Global Tumor Marker ELISA Kit Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Tumor Marker ELISA Kit Players Market Share by Revenue

2.8.3 Global Tumor Marker ELISA Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Tumor Marker ELISA Kit Market Scenario by Region

3.1 Global Tumor Marker ELISA Kit Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Tumor Marker ELISA Kit Sales by Region: 2019-2030

3.2.1 Global Tumor Marker ELISA Kit Sales by Region: 2019-2024

3.2.2 Global Tumor Marker ELISA Kit Sales by Region: 2025-2030

3.3 Global Tumor Marker ELISA Kit Revenue by Region: 2019-2030

3.3.1 Global Tumor Marker ELISA Kit Revenue by Region: 2019-2024

3.3.2 Global Tumor Marker ELISA Kit Revenue by Region: 2025-2030

3.4 North America Tumor Marker ELISA Kit Market Facts & Figures by Country

3.4.1 North America Tumor Marker ELISA Kit Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Tumor Marker ELISA Kit Sales by Country (2019-2030)

3.4.3 North America Tumor Marker ELISA Kit Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Tumor Marker ELISA Kit Market Facts & Figures by Country

3.5.1 Europe Tumor Marker ELISA Kit Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Tumor Marker ELISA Kit Sales by Country (2019-2030)

3.5.3 Europe Tumor Marker ELISA Kit Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Tumor Marker ELISA Kit Market Facts & Figures by Region

3.6.1 Asia Pacific Tumor Marker ELISA Kit Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Tumor Marker ELISA Kit Sales by Region (2019-2030)

3.6.3 Asia Pacific Tumor Marker ELISA Kit Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Tumor Marker ELISA Kit Market Facts & Figures by Country

3.7.1 Latin America Tumor Marker ELISA Kit Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Tumor Marker ELISA Kit Sales by Country (2019-2030)

3.7.3 Latin America Tumor Marker ELISA Kit Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Tumor Marker ELISA Kit Market Facts & Figures by Country

3.8.1 Middle East and Africa Tumor Marker ELISA Kit Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Tumor Marker ELISA Kit Sales by Country (2019-2030)

3.8.3 Middle East and Africa Tumor Marker ELISA Kit Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Tumor Marker ELISA Kit Sales by Type (2019-2030)

4.1.1 Global Tumor Marker ELISA Kit Sales by Type (2019-2024)

4.1.2 Global Tumor Marker ELISA Kit Sales by Type (2025-2030)

4.1.3 Global Tumor Marker ELISA Kit Sales Market Share by Type (2019-2030)

4.2 Global Tumor Marker ELISA Kit Revenue by Type (2019-2030)

4.2.1 Global Tumor Marker ELISA Kit Revenue by Type (2019-2024)

4.2.2 Global Tumor Marker ELISA Kit Revenue by Type (2025-2030)

4.2.3 Global Tumor Marker ELISA Kit Revenue Market Share by Type (2019-2030)

4.3 Global Tumor Marker ELISA Kit Price by Type (2019-2030)

5 Segment by Application

5.1 Global Tumor Marker ELISA Kit Sales by Application (2019-2030)

5.1.1 Global Tumor Marker ELISA Kit Sales by Application (2019-2024)

5.1.2 Global Tumor Marker ELISA Kit Sales by Application (2025-2030)

5.1.3 Global Tumor Marker ELISA Kit Sales Market Share by Application (2019-2030)

5.2 Global Tumor Marker ELISA Kit Revenue by Application (2019-2030)

5.2.1 Global Tumor Marker ELISA Kit Revenue by Application (2019-2024)

5.2.2 Global Tumor Marker ELISA Kit Revenue by Application (2025-2030)

5.2.3 Global Tumor Marker ELISA Kit Revenue Market Share by Application (2019-2030)

5.3 Global Tumor Marker ELISA Kit Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Thermo Fisher Scientific

6.1.1 Thermo Fisher Scientific Company Information

6.1.2 Thermo Fisher Scientific Description and Business Overview

6.1.3 Thermo Fisher Scientific Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Thermo Fisher Scientific Tumor Marker ELISA Kit Product Portfolio

6.1.5 Thermo Fisher Scientific Recent Developments/Updates

6.2 Fujirebio

6.2.1 Fujirebio Company Information

6.2.2 Fujirebio Description and Business Overview

6.2.3 Fujirebio Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Fujirebio Tumor Marker ELISA Kit Product Portfolio

6.2.5 Fujirebio Recent Developments/Updates

6.3 Siemens Healthineers

6.3.1 Siemens Healthineers Company Information

6.3.2 Siemens Healthineers Description and Business Overview

6.3.3 Siemens Healthineers Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Siemens Healthineers Tumor Marker ELISA Kit Product Portfolio

6.3.5 Siemens Healthineers Recent Developments/Updates

6.4 Roche Holding

6.4.1 Roche Holding Company Information

6.4.2 Roche Holding Description and Business Overview

6.4.3 Roche Holding Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Roche Holding Tumor Marker ELISA Kit Product Portfolio

6.4.5 Roche Holding Recent Developments/Updates

6.5 Cusabio

6.5.1 Cusabio Company Information

6.5.2 Cusabio Description and Business Overview

6.5.3 Cusabio Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Cusabio Tumor Marker ELISA Kit Product Portfolio

6.5.5 Cusabio Recent Developments/Updates

6.6 Epitope Diagnostics

6.6.1 Epitope Diagnostics Company Information

6.6.2 Epitope Diagnostics Description and Business Overview

6.6.3 Epitope Diagnostics Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Epitope Diagnostics Tumor Marker ELISA Kit Product Portfolio

6.6.5 Epitope Diagnostics Recent Developments/Updates

6.7 Getein Biotech

6.7.1 Getein Biotech Company Information

6.7.2 Getein Biotech Description and Business Overview

6.7.3 Getein Biotech Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Getein Biotech Tumor Marker ELISA Kit Product Portfolio

6.7.5 Getein Biotech Recent Developments/Updates

6.8 Creative Diagnostics

6.8.1 Creative Diagnostics Company Information

6.8.2 Creative Diagnostics Description and Business Overview

6.8.3 Creative Diagnostics Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Creative Diagnostics Tumor Marker ELISA Kit Product Portfolio

6.8.5 Creative Diagnostics Recent Developments/Updates

6.9 Artron Laboratories

6.9.1 Artron Laboratories Company Information

6.9.2 Artron Laboratories Description and Business Overview

6.9.3 Artron Laboratories Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Artron Laboratories Tumor Marker ELISA Kit Product Portfolio

6.9.5 Artron Laboratories Recent Developments/Updates

6.10 InTec

6.10.1 InTec Company Information

6.10.2 InTec Description and Business Overview

6.10.3 InTec Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.10.4 InTec Tumor Marker ELISA Kit Product Portfolio

6.10.5 InTec Recent Developments/Updates

6.11 JOYSBIO

6.11.1 JOYSBIO Company Information

6.11.2 JOYSBIO Description and Business Overview

6.11.3 JOYSBIO Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.11.4 JOYSBIO Tumor Marker ELISA Kit Product Portfolio

6.11.5 JOYSBIO Recent Developments/Updates

6.12 Orient Gene

6.12.1 Orient Gene Company Information

6.12.2 Orient Gene Description and Business Overview

6.12.3 Orient Gene Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Orient Gene Tumor Marker ELISA Kit Product Portfolio

6.12.5 Orient Gene Recent Developments/Updates

6.13 Assure Tech

6.13.1 Assure Tech Company Information

6.13.2 Assure Tech Description and Business Overview

6.13.3 Assure Tech Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Assure Tech Tumor Marker ELISA Kit Product Portfolio

6.13.5 Assure Tech Recent Developments/Updates

6.14 Microprofit Biotech

6.14.1 Microprofit Biotech Company Information

6.14.2 Microprofit Biotech Description and Business Overview

6.14.3 Microprofit Biotech Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Microprofit Biotech Tumor Marker ELISA Kit Product Portfolio

6.14.5 Microprofit Biotech Recent Developments/Updates

6.15 Hotgen Biotech

6.15.1 Hotgen Biotech Company Information

6.15.2 Hotgen Biotech Description and Business Overview

6.15.3 Hotgen Biotech Tumor Marker ELISA Kit Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Hotgen Biotech Tumor Marker ELISA Kit Product Portfolio

6.15.5 Hotgen Biotech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Tumor Marker ELISA Kit Industry Chain Analysis

7.2 Tumor Marker ELISA Kit Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Tumor Marker ELISA Kit Production Mode & Process

7.4 Tumor Marker ELISA Kit Sales and Marketing

7.4.1 Tumor Marker ELISA Kit Sales Channels

7.4.2 Tumor Marker ELISA Kit Distributors

7.5 Tumor Marker ELISA Kit Customers

8 Tumor Marker ELISA Kit Market Dynamics

8.1 Tumor Marker ELISA Kit Industry Trends

8.2 Tumor Marker ELISA Kit Market Drivers

8.3 Tumor Marker ELISA Kit Market Challenges

8.4 Tumor Marker ELISA Kit Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Tumor Marker ELISA Kit Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Tumor Marker ELISA Kit Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Tumor Marker ELISA Kit Market Competitive Situation by Manufacturers in 2023

Table 4. Global Tumor Marker ELISA Kit Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Tumor Marker ELISA Kit Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Tumor Marker ELISA Kit Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Tumor Marker ELISA Kit Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Tumor Marker ELISA Kit Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Tumor Marker ELISA Kit, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Tumor Marker ELISA Kit, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Tumor Marker ELISA Kit, Product Type & Application

Table 12. Global Key Manufacturers of Tumor Marker ELISA Kit, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Tumor Marker ELISA Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Marker ELISA Kit as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Tumor Marker ELISA Kit Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Tumor Marker ELISA Kit Sales by Region (2019-2024) & (K Units)

Table 18. Global Tumor Marker ELISA Kit Sales Market Share by Region (2019-2024)

Table 19. Global Tumor Marker ELISA Kit Sales by Region (2025-2030) & (K Units)

Table 20. Global Tumor Marker ELISA Kit Sales Market Share by Region (2025-2030)

Table 21. Global Tumor Marker ELISA Kit Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Tumor Marker ELISA Kit Revenue Market Share by Region (2019-2024)

Table 23. Global Tumor Marker ELISA Kit Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Tumor Marker ELISA Kit Revenue Market Share by Region (2025-2030)

Table 25. North America Tumor Marker ELISA Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Tumor Marker ELISA Kit Sales by Country (2019-2024) & (K Units)

Table 27. North America Tumor Marker ELISA Kit Sales by Country (2025-2030) & (K Units)

Table 28. North America Tumor Marker ELISA Kit Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Tumor Marker ELISA Kit Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Tumor Marker ELISA Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Tumor Marker ELISA Kit Sales by Country (2019-2024) & (K Units)

Table 32. Europe Tumor Marker ELISA Kit Sales by Country (2025-2030) & (K Units)

Table 33. Europe Tumor Marker ELISA Kit Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Tumor Marker ELISA Kit Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Tumor Marker ELISA Kit Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Tumor Marker ELISA Kit Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Tumor Marker ELISA Kit Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Tumor Marker ELISA Kit Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Tumor Marker ELISA Kit Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Tumor Marker ELISA Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Tumor Marker ELISA Kit Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Tumor Marker ELISA Kit Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Tumor Marker ELISA Kit Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Tumor Marker ELISA Kit Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Tumor Marker ELISA Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Tumor Marker ELISA Kit Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Tumor Marker ELISA Kit Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Tumor Marker ELISA Kit Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Tumor Marker ELISA Kit Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Tumor Marker ELISA Kit Sales (K Units) by Type (2019-2024)

Table 51. Global Tumor Marker ELISA Kit Sales (K Units) by Type (2025-2030)

Table 52. Global Tumor Marker ELISA Kit Sales Market Share by Type (2019-2024)

Table 53. Global Tumor Marker ELISA Kit Sales Market Share by Type (2025-2030)

Table 54. Global Tumor Marker ELISA Kit Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Tumor Marker ELISA Kit Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Tumor Marker ELISA Kit Revenue Market Share by Type (2019-2024)

Table 57. Global Tumor Marker ELISA Kit Revenue Market Share by Type (2025-2030)

Table 58. Global Tumor Marker ELISA Kit Price (US$/Unit) by Type (2019-2024)

Table 59. Global Tumor Marker ELISA Kit Price (US$/Unit) by Type (2025-2030)

Table 60. Global Tumor Marker ELISA Kit Sales (K Units) by Application (2019-2024)

Table 61. Global Tumor Marker ELISA Kit Sales (K Units) by Application (2025-2030)

Table 62. Global Tumor Marker ELISA Kit Sales Market Share by Application (2019-2024)

Table 63. Global Tumor Marker ELISA Kit Sales Market Share by Application (2025-2030)

Table 64. Global Tumor Marker ELISA Kit Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Tumor Marker ELISA Kit Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Tumor Marker ELISA Kit Revenue Market Share by Application (2019-2024)

Table 67. Global Tumor Marker ELISA Kit Revenue Market Share by Application (2025-2030)

Table 68. Global Tumor Marker ELISA Kit Price (US$/Unit) by Application (2019-2024)

Table 69. Global Tumor Marker ELISA Kit Price (US$/Unit) by Application (2025-2030)

Table 70. Thermo Fisher Scientific Company Information

Table 71. Thermo Fisher Scientific Description and Business Overview

Table 72. Thermo Fisher Scientific Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Thermo Fisher Scientific Tumor Marker ELISA Kit Product

Table 74. Thermo Fisher Scientific Recent Developments/Updates

Table 75. Fujirebio Company Information

Table 76. Fujirebio Description and Business Overview

Table 77. Fujirebio Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Fujirebio Tumor Marker ELISA Kit Product

Table 79. Fujirebio Recent Developments/Updates

Table 80. Siemens Healthineers Company Information

Table 81. Siemens Healthineers Description and Business Overview

Table 82. Siemens Healthineers Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Siemens Healthineers Tumor Marker ELISA Kit Product

Table 84. Siemens Healthineers Recent Developments/Updates

Table 85. Roche Holding Company Information

Table 86. Roche Holding Description and Business Overview

Table 87. Roche Holding Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Roche Holding Tumor Marker ELISA Kit Product

Table 89. Roche Holding Recent Developments/Updates

Table 90. Cusabio Company Information

Table 91. Cusabio Description and Business Overview

Table 92. Cusabio Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Cusabio Tumor Marker ELISA Kit Product

Table 94. Cusabio Recent Developments/Updates

Table 95. Epitope Diagnostics Company Information

Table 96. Epitope Diagnostics Description and Business Overview

Table 97. Epitope Diagnostics Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Epitope Diagnostics Tumor Marker ELISA Kit Product

Table 99. Epitope Diagnostics Recent Developments/Updates

Table 100. Getein Biotech Company Information

Table 101. Getein Biotech Description and Business Overview

Table 102. Getein Biotech Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Getein Biotech Tumor Marker ELISA Kit Product

Table 104. Getein Biotech Recent Developments/Updates

Table 105. Creative Diagnostics Company Information

Table 106. Creative Diagnostics Description and Business Overview

Table 107. Creative Diagnostics Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Creative Diagnostics Tumor Marker ELISA Kit Product

Table 109. Creative Diagnostics Recent Developments/Updates

Table 110. Artron Laboratories Company Information

Table 111. Artron Laboratories Description and Business Overview

Table 112. Artron Laboratories Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Artron Laboratories Tumor Marker ELISA Kit Product

Table 114. Artron Laboratories Recent Developments/Updates

Table 115. InTec Company Information

Table 116. InTec Description and Business Overview

Table 117. InTec Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. InTec Tumor Marker ELISA Kit Product

Table 119. InTec Recent Developments/Updates

Table 120. JOYSBIO Company Information

Table 121. JOYSBIO Description and Business Overview

Table 122. JOYSBIO Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. JOYSBIO Tumor Marker ELISA Kit Product

Table 124. JOYSBIO Recent Developments/Updates

Table 125. Orient Gene Company Information

Table 126. Orient Gene Description and Business Overview

Table 127. Orient Gene Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Orient Gene Tumor Marker ELISA Kit Product

Table 129. Orient Gene Recent Developments/Updates

Table 130. Assure Tech Company Information

Table 131. Assure Tech Description and Business Overview

Table 132. Assure Tech Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Assure Tech Tumor Marker ELISA Kit Product

Table 134. Assure Tech Recent Developments/Updates

Table 135. Microprofit Biotech Company Information

Table 136. Microprofit Biotech Description and Business Overview

Table 137. Microprofit Biotech Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Microprofit Biotech Tumor Marker ELISA Kit Product

Table 139. Microprofit Biotech Recent Developments/Updates

Table 140. Hotgen Biotech Company Information

Table 141. Hotgen Biotech Description and Business Overview

Table 142. Hotgen Biotech Tumor Marker ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Hotgen Biotech Tumor Marker ELISA Kit Product

Table 144. Hotgen Biotech Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Tumor Marker ELISA Kit Distributors List

Table 148. Tumor Marker ELISA Kit Customers List

Table 149. Tumor Marker ELISA Kit Market Trends

Table 150. Tumor Marker ELISA Kit Market Drivers

Table 151. Tumor Marker ELISA Kit Market Challenges

Table 152. Tumor Marker ELISA Kit Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Tumor Marker ELISA Kit

Figure 2. Global Tumor Marker ELISA Kit Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Tumor Marker ELISA Kit Market Share by Type: 2023 & 2030

Figure 4. Blood Testing Product Picture

Figure 5. Urine Testing Product Picture

Figure 6. Others Product Picture

Figure 7. Global Tumor Marker ELISA Kit Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global Tumor Marker ELISA Kit Market Share by Application: 2023 & 2030

Figure 9. Lung Cancer

Figure 10. Breast Cancer

Figure 11. Stomach Cancer

Figure 12. Liver Cancer

Figure 13. Esophageal Cancer

Figure 14. Others

Figure 15. Global Tumor Marker ELISA Kit Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Tumor Marker ELISA Kit Market Size (2019-2030) & (US$ Million)

Figure 17. Global Tumor Marker ELISA Kit Sales (2019-2030) & (K Units)

Figure 18. Global Tumor Marker ELISA Kit Average Price (US$/Unit) & (2019-2030)

Figure 19. Tumor Marker ELISA Kit Report Years Considered

Figure 20. Tumor Marker ELISA Kit Sales Share by Manufacturers in 2023

Figure 21. Global Tumor Marker ELISA Kit Revenue Share by Manufacturers in 2023

Figure 22. Global 5 and 10 Largest Tumor Marker ELISA Kit Players: Market Share by Revenue in Tumor Marker ELISA Kit in 2023

Figure 23. Tumor Marker ELISA Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 24. Global Tumor Marker ELISA Kit Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Tumor Marker ELISA Kit Sales Market Share by Country (2019-2030)

Figure 26. North America Tumor Marker ELISA Kit Revenue Market Share by Country (2019-2030)

Figure 27. United States Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Tumor Marker ELISA Kit Sales Market Share by Country (2019-2030)

Figure 30. Europe Tumor Marker ELISA Kit Revenue Market Share by Country (2019-2030)

Figure 31. Germany Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Tumor Marker ELISA Kit Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Tumor Marker ELISA Kit Revenue Market Share by Region (2019-2030)

Figure 38. China Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. China Taiwan Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Tumor Marker ELISA Kit Sales Market Share by Country (2019-2030)

Figure 46. Mexico Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Colombia Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East and Africa Tumor Marker ELISA Kit Sales Market Share by Country (2019-2030)

Figure 51. Middle East and Africa Tumor Marker ELISA Kit Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Tumor Marker ELISA Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Tumor Marker ELISA Kit by Type (2019-2030)

Figure 56. Global Revenue Market Share of Tumor Marker ELISA Kit by Type (2019-2030)

Figure 57. Global Tumor Marker ELISA Kit Price (US$/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Tumor Marker ELISA Kit by Application (2019-2030)

Figure 59. Global Revenue Market Share of Tumor Marker ELISA Kit by Application (2019-2030)

Figure 60. Global Tumor Marker ELISA Kit Price (US$/Unit) by Application (2019-2030)

Figure 61. Tumor Marker ELISA Kit Value Chain

Figure 62. Tumor Marker ELISA Kit Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Tumor Marker ELISA Kit market size from 2024 to 2030? zhanKai

The annual compound growth rate of the global Tumor Marker ELISA Kit market is 7.4% 2024 to 2030.

Which companies rank high in the global Tumor Marker ELISA Kit market? shouQi

What was the global market size of Tumor Marker ELISA Kit in 2030? shouQi

What was the global market size of Tumor Marker ELISA Kit in 2024? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Tumor Marker ELISA Kit Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Tumor Marker ELISA Kit market is projected to grow from US$ 3055 million in 2025 to US$ 5000 million by 2032, at a CAGR of 7.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 169
USD 4900.00
(Single User License)
Global Tumor Marker ELISA Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Tumor Marker ELISA Kit market size was US$ 3055 million in 2025 and is forecast to reach a readjusted size of US$ 5000 million by 2032 with a CAGR of 7.4% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 99
USD 4250.00
(Single User License)
Tumor Marker ELISA Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tumor Marker ELISA Kit was estimated to be worth US$ 3055 million in 2025 and is projected to reach US$ 5000 million, growing at a CAGR of 7.4% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 117
USD 3950.00
(Single User License)
Global Tumor Marker ELISA Kit Market Research Report 2026
The global Tumor Marker ELISA Kit market was valued at US$ 3055 million in 2025 and is anticipated to reach US$ 5000 million by 2032, at a CAGR of 7.4% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 118
USD 2900.00
(Single User License)
Global Tumor Marker ELISA Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tumor Marker ELISA Kit market is projected to grow from US$ 2864 million in 2024 to US$ 4688 million by 2031, at a CAGR of 7.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 161
USD 4900.00
(Single User License)
Global Tumor Marker ELISA Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tumor Marker ELISA Kit market size was US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 4688 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 92
USD 4250.00
(Single User License)
Tumor Marker ELISA Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tumor Marker ELISA Kit was estimated to be worth US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 4688 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 125
USD 3950.00
(Single User License)
Global Tumor Marker ELISA Kit Market Research Report 2025
The global market for Tumor Marker ELISA Kit was valued at US$ 2864 million in the year 2024 and is projected to reach a revised size of US$ 4688 million by 2031, growing at a CAGR of 7.4% during the forecast period.
Published Date: 2025-03-10
Pages: 91
USD 2900.00
(Single User License)
Global and United States Tumor Marker ELISA Kit Market Report & Forecast 2024-2030
Tumor marker ELISA kit (enzyme-linked immunosorbent assay kit) is a tool used to detect the content of tumor markers in biological samples (such as blood, serum, plasma, tissue homogenate, etc.). ELISA (enzyme-linked immunosorbent assay) is a detection technology based on antigen-antibody specific reaction, and this kit applies this technology to the detection of tumor markers. It mainly uses the specific binding reaction between antigen and antibody.
Published Date: 2024-10-27
Pages: 128
USD 4350.00
(Single User License)
Global Tumor Marker ELISA Kit Market Insights, Forecast to 2030
Tumor marker ELISA kit (enzyme-linked immunosorbent assay kit) is a tool used to detect the content of tumor markers in biological samples (such as blood, serum, plasma, tissue homogenate, etc.). ELISA (enzyme-linked immunosorbent assay) is a detection technology based on antigen-antibody specific reaction, and this kit applies this technology to the detection of tumor markers. It mainly uses the specific binding reaction between antigen and antibody.
Published Date: 2024-10-27
Pages: 163
USD 4900.00
(Single User License)

Global Tumor Marker ELISA Kit Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Tumor Marker ELISA Kit market is projected to grow from US$ 3055 million in 2025 to US$ 5000 million by 2032, at a CAGR of 7.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 169
USD 4900.00 (Single User License)
Global Tumor Marker ELISA Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Tumor Marker ELISA Kit market size was US$ 3055 million in 2025 and is forecast to reach a readjusted size of US$ 5000 million by 2032 with a CAGR of 7.4% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 99
USD 4250.00 (Single User License)
Tumor Marker ELISA Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tumor Marker ELISA Kit was estimated to be worth US$ 3055 million in 2025 and is projected to reach US$ 5000 million, growing at a CAGR of 7.4% from 2026 to 2032.
Published: 2026-01-08
Pages: 117
USD 3950.00 (Single User License)
Global Tumor Marker ELISA Kit Market Research Report 2026
The global Tumor Marker ELISA Kit market was valued at US$ 3055 million in 2025 and is anticipated to reach US$ 5000 million by 2032, at a CAGR of 7.4% from 2026 to 2032.
Published: 2026-01-08
Pages: 118
USD 2900.00 (Single User License)
Global Tumor Marker ELISA Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tumor Marker ELISA Kit market is projected to grow from US$ 2864 million in 2024 to US$ 4688 million by 2031, at a CAGR of 7.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 161
USD 4900.00 (Single User License)
Global Tumor Marker ELISA Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tumor Marker ELISA Kit market size was US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 4688 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 92
USD 4250.00 (Single User License)
Tumor Marker ELISA Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tumor Marker ELISA Kit was estimated to be worth US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 4688 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 125
USD 3950.00 (Single User License)
Global Tumor Marker ELISA Kit Market Research Report 2025
The global market for Tumor Marker ELISA Kit was valued at US$ 2864 million in the year 2024 and is projected to reach a revised size of US$ 4688 million by 2031, growing at a CAGR of 7.4% during the forecast period.
Published: 2025-03-10
Pages: 91
USD 2900.00 (Single User License)
Global and United States Tumor Marker ELISA Kit Market Report & Forecast 2024-2030
Tumor marker ELISA kit (enzyme-linked immunosorbent assay kit) is a tool used to detect the content of tumor markers in biological samples (such as blood, serum, plasma, tissue homogenate, etc.). ELISA (enzyme-linked immunosorbent assay) is a detection technology based on antigen-antibody specific reaction, and this kit applies this technology to the detection of tumor markers. It mainly uses the specific binding reaction between antigen and antibody.
Published: 2024-10-27
Pages: 128
USD 4350.00 (Single User License)
Global Tumor Marker ELISA Kit Market Insights, Forecast to 2030
Tumor marker ELISA kit (enzyme-linked immunosorbent assay kit) is a tool used to detect the content of tumor markers in biological samples (such as blood, serum, plasma, tissue homogenate, etc.). ELISA (enzyme-linked immunosorbent assay) is a detection technology based on antigen-antibody specific reaction, and this kit applies this technology to the detection of tumor markers. It mainly uses the specific binding reaction between antigen and antibody.
Published: 2024-10-27
Pages: 163
USD 4900.00 (Single User License)